THIS SITE REQUIRES FLASH™ PLAYER VERSION 8

Please take this time to equip your browser with the Flash 8 Plugin. It's small, fast, and free.

FACTS
Over 93% of browsers on the Internet are equipped with the Flash™ plugin.
Most of web sites today uses Flash technology one way or another.
You need to update your browser.

Click the button below to get it. After that, come back to this page and hit refresh!

Get Flash Player NOW!

Thank you for your patience.

PRODUCTS > SENTIONYL


SENTIONYL 5 mg tablet

Generic Name: Glibenclamide
Registration Status: registered
Drug Type: ANTI-DIABETIC DRUGS
Principal: The ACME Laboratories LTD

Description:
SENTIONYL is Glibenclamide, a second generation sulphonylurea. Glibenclamide (Sentionyl) is used in the management of non-insulin dependent diabetes mellitus (NIDDM). Glibenclamide (Sentionyl) causes degranulation of the -cells in the pancreas resulting in insulin secretion and increases the number of insulin receptors in fat, skeletal muscle and liver. In both short term and long term administration in diabetes, Glibenclamide (Sentionyl) maintains the glucose level in body by reducing the blood glucose level. Glibenclamide (Sentionyl) is indicated in the treatment and control of blood sugar in non-insulin dependent diabetes mellitus (NIDDM) patients, when hyperglycemia is not adequately controlled by diet alone. Glibenclamide (Sentionyl) is only indicated to NIDDM patients.


  
Home : About Us: Products : Services : Principals : Links : Contact
Email Login
© 2006 EURO GENERICS INTERNATIONAL PHILIPPINES :: Website crafted by TeaConcepts